CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 35 of 48

Rheumatology (Oxford)

Briefs 1,361–1,400 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Occupational impacts of early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit

    Cohort studyAcross diseases

  2. Rheumatology (Oxford)

    Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease

    Cohort studySystemic sclerosis

  3. Rheumatology (Oxford)

    The chest CT signs for pulmonary veno-occlusive disease correlate with pulmonary haemodynamics in systemic sclerosis

    Cross-sectional studySystemic sclerosis

  4. Rheumatology (Oxford)

    Tolerability and comparative effectiveness of TNF, IL-17 and IL-23(p19) inhibitors in psoriatic arthritis: a target trial emulation study

    Cohort studySpondyloarthritis & PsA

  5. Rheumatology (Oxford)

    Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry

    Cross-sectional studyMyositis

  6. Rheumatology (Oxford)

    Extra-osseous manifestations in chronic recurrent multifocal osteomyelitis: a retrospective study

    Cohort studyPediatric

  7. Rheumatology (Oxford)

    The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study

    Cohort studySystemic sclerosis

  8. Rheumatology (Oxford)

    Hand joints without radiographic osteoarthritis maintain their joint space width over 4 years despite what’s happening elsewhere in the hand

    Cohort studyOsteoarthritis

  9. Rheumatology (Oxford)

    The Tophus Impact Questionnaire (TIQ-20): responsiveness to change during urate-lowering therapy

    Secondary analysisGout & crystals

  10. Rheumatology (Oxford)

    Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals

    Cohort studyRA

  11. Rheumatology (Oxford)

    Analgesic prescribing in patients with inflammatory arthritis in England: observational studies in the Clinical Practice Research Datalink

    Cross-sectional studyAcross diseases

  12. Rheumatology (Oxford)

    Biologic disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint counts

    Cohort studySpondyloarthritis & PsA

  13. Rheumatology (Oxford)

    Defining the physician global assessment threshold equivalent to remission in patients with systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  14. Rheumatology (Oxford)

    Outcomes following switching from etanercept originator to etanercept biosimilar in 1024 patients with RA: a matched-analysis of the BSRBR-RA

    Cohort studyRA

  15. Rheumatology (Oxford)

    Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review

    Research articleVasculitis & PMR

  16. Rheumatology (Oxford)

    Adenosine 5’monophosphate-activated protein kinase activation reduces the risks of psoriasis and its comorbidities: a Mendelian randomization study in the UK Biobank

    Diagnostic or prognostic study

  17. Rheumatology (Oxford)

    Large vessel involvement in antineutrophil cytoplasmic antibody-associated vasculitis

    Cohort studyVasculitis & PMR

  18. Rheumatology (Oxford)

    Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy

    Cohort studySystemic sclerosis

  19. Rheumatology (Oxford)

    Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts

    Guideline or statementAutoinflammatory & rare

  20. Rheumatology (Oxford)

    Sirtuin 1 overexpression contributes to the expansion of follicular helper T cells in systemic lupus erythematosus and may serve as an accessible therapeutic target

    Mechanistic studyLupus & APS

  21. Rheumatology (Oxford)

    TLR8 aggravates skin inflammation and fibrosis by activating skin fibroblasts in systemic sclerosis

    Mechanistic studySystemic sclerosis

  22. Rheumatology (Oxford)

    Psoriatic arthritis risk in psoriasis patients prescribed acitretin versus disease-modifying antirheumatic drugs: a nationwide cohort study

    Cohort studySpondyloarthritis & PsA

  23. Rheumatology (Oxford)

    Phenotypic and genotypic characterization of Chinese adult patients with NLRP3-associated autoinflammatory disease with hearing loss

    Cohort studyAutoinflammatory & rare

  24. Rheumatology (Oxford)

    Disparities in multimorbidity and comorbidities in rheumatoid arthritis by sex across the lifespan

    Cross-sectional studyRA

  25. Rheumatology (Oxford)

    Prior polymyalgia rheumatica is associated with sonographic vasculitic changes in newly diagnosed patients with giant cell arteritis

    Cohort studyVasculitis & PMR

  26. Rheumatology (Oxford)

    Baseline predictors of disease severity in immune checkpoint inhibitor-induced inflammatory arthritis

    Cohort studyAcross diseases

  27. Rheumatology (Oxford)

    Adherence to therapy of ixekizumab and secukinumab in psoriatic arthritis patients using first- or second-line IL-17A inhibitor treatment: a Danish population-based cohort study

    Cohort studySpondyloarthritis & PsA

  28. Rheumatology (Oxford)

    Body composition parameters in systemic sclerosis—a systematic review and meta-analysis

    Meta-analysisSystemic sclerosis

  29. Rheumatology (Oxford)

    Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity

    Cohort studyPediatric

  30. Rheumatology (Oxford)

    Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases

    Cohort studyVasculitis & PMR

  31. Rheumatology (Oxford)

    Renal relapse in children and adolescents with childhood-onset lupus nephritis: a 20-year study

    Cohort studyPediatric

  32. Rheumatology (Oxford)

    Prediction model for respiratory-related mortality in microscopic polyangiitis with interstitial lung disease: multicentre REVEAL cohort study

    Diagnostic or prognostic studyVasculitis & PMR

  33. Rheumatology (Oxford)

    Patients with rheumatoid arthritis presenting with mono- or oligo-arthritis and high VAS-ratings remain the most fatigued during 5 years of follow-up

    Cohort studyRA

  34. Rheumatology (Oxford)

    Mortality and causes of death in systemic lupus erythematosus in New Zealand: a population-based study

    Cohort studyLupus & APS

  35. Rheumatology (Oxford)

    Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis

    Cross-sectional studySystemic sclerosis

  36. Rheumatology (Oxford)

    Feasibility of conducting a cohort randomized controlled trial assessing the effectiveness of a nurse-led package of care for knee pain

    Randomized controlled trialOsteoarthritis

  37. Rheumatology (Oxford)

    Association between the initial dose urate-lowering drugs and gout flares in adult males with gout

    Cohort studyGout & crystals

  38. Rheumatology (Oxford)

    Evaluation of belimumab in treatment of Chinese childhood-onset systemic lupus erythematosus: a prospective analysis from a multicentre study

    Cohort studyPediatric

  39. Rheumatology (Oxford)

    Characterizing the lavage and serum cytokine profiles of interstitial pneumonia with autoimmune features and their implications for progressive fibrosis

    Cohort study

  40. Rheumatology (Oxford)

    Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome

    Diagnostic or prognostic studyAutoinflammatory & rare

All 1,905 Briefs in ExploreShowing Briefs 1,361–1,400 of 1,905, newest first